Phosphodiesterase 5 Inhibitors
Showing 1 - 25 of >10,000
Carotid Artery Intima Media Thickness Can Predict Response to
Completed
- Erectile Dysfunction Due to Arterial Disease
- CIMT (Carotid artery intima media thickness measurement)
-
Bursa, TurkeyBursa Yuksek Ihtisas Training and Research Hospital
Jan 11, 2023
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)
Not yet recruiting
- Single-ventricle
- +2 more
- Sildenafil
- Placebos
- (no location specified)
Jan 20, 2022
Pulmonary Hypertension, COPD Trial (Tadalafil)
Not yet recruiting
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Apr 25, 2023
Erectile Dysfunction Trial in Garches (Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH), Placebo
Recruiting
- Erectile Dysfunction
- Investigational product administration Xeomin® (MERZ PHARMACEUTICALS GMBH)
- Placebo administration
-
Garches, FranceNeuro-Urology-Andrology, Physical Medicine and Rehabilitation De
Mar 28, 2022
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In
Completed
- Erectile Dysfunction
- (no location specified)
Jan 28, 2021
Erectile Dysfunction Trial in Banha (OnabotulinumtoxinA, Trimix)
Recruiting
- Erectile Dysfunction
- OnabotulinumtoxinA
- Trimix
-
Banha, Kalubiaya, EgyptBanha University Hospitals
Jan 6, 2022
Glaucoma Trial in London (Sildenafil 100mg)
Suspended
- Glaucoma
- Sildenafil 100mg
-
London, United KingdomWestern Eye Hospital
Jan 21, 2021
IBD Trial (Pentoxifylline 400 MG)
Not yet recruiting
- Inflammatory Bowel Diseases
- Pentoxifylline 400 MG
- (no location specified)
Oct 28, 2022
Behçet's Disease Trial in Beijing (Hemay005, Placebo)
Recruiting
- Behçet's Disease
- Hemay005
- Placebo
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 17, 2023
Phosphodiesterase Type 5 Inhibitor to Improve Anabolic
Not yet recruiting
- Sarcopenia
- Tadalafil 5mg
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jul 25, 2022
MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)
Recruiting
- Major Depressive Disorder
- Sildenafil Citrate
- Placebo oral tablet
-
Shibīn Al Kawm, EgyptFaculty of Medicine
Jan 16, 2023
Heart Defects, Congenital, Transposition of Great Vessels With Ventricular Inversion Trial in Austria, Switzerland (Tadalafil 20
Completed
- Heart Defects, Congenital
- Transposition of Great Vessels With Ventricular Inversion
- Tadalafil 20 MG
- Placebo 20 MG
-
Wien, Austria
- +6 more
Feb 23, 2022
Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on
Completed
- Pulmonary Arterial Hypertension
- no intervention, only observation of different groups
-
Heidelberg, GermanyCentre for pulmonary hypertension, Thoraxclinic at the Universit
Jan 24, 2020
Erectile Dysfunction, Sexual Dysfunction Trial in Salt Lake City (Natesto Nasal Product, Placebo)
Recruiting
- Erectile Dysfunction
- Sexual Dysfunction
- Natesto Nasal Product
- Placebo
-
Salt Lake City, UtahUniversity of Utah, Division of Urology
Aug 11, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)
Completed
- Pulmonary Arterial Hypertension
- Riociguat (Adempas, BAY63-2521)
- +2 more
-
Phoenix, Arizona
- +80 more
Feb 3, 2021
Congenital Diaphragmatic Hernia, Pulmonary Hypertension Trial in Salt Lake City (Sildenafil Oral Suspension, Placebo)
Not yet recruiting
- Congenital Diaphragmatic Hernia
- Pulmonary Hypertension
- Sildenafil Oral Suspension
- Placebo
-
Salt Lake City, UtahPrimary Children's Hospital
Jan 27, 2022
ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin
Active, not recruiting
- Pulmonary Arterial Hypertension
- PDE5 inhibitor
- Endothelin Receptor Antagonists
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021
Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))
Not yet recruiting
- Generalized Myasthenia Gravis
- zilucoplan (RA101495)
- (no location specified)
Aug 22, 2022
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
Learn About Use and Effects of CDK4/6 Inhibitors in Canadian
Active, not recruiting
- Breast Cancer
-
Kirkland, Quebec, CanadaPfizer Canada
Mar 5, 2023
MDD Trial in Shibin Al Kawm (Tadalafil 5Mg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Tadalafil 5Mg Tab
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Aug 31, 2021